ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,245.37
-0.48%
Dow Jones
38,798.99
-0.22%
Gold vs US Dollar
2,293.845
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,474.03
0.20%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. FSD Pharma Inc (HUGE)

  7. FSD Pharma Inc (HUGE) News

FSD Pharma (HUGE)

FSD Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HUGE
DateTimeSourceHeadlineSymbolCompany
04/06/202413:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
31/05/202412:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
28/05/202413:15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
24/05/202421:51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
16/05/202413:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
07/05/202413:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
11/03/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
05/03/202413:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
28/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
26/02/202413:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
20/02/202411:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
20/02/202411:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
07/02/202421:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
07/02/202420:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
16/01/202412:38Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
11/01/202418:10GlobeNewswire Inc.GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss CaseNASDAQ:HUGEFSD Pharma Inc
05/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HUGEFSD Pharma Inc
26/12/202311:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
21/12/202321:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
18/12/202317:31Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:HUGEFSD Pharma Inc
15/12/202314:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
15/12/202314:46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
15/12/202314:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
15/12/202314:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
15/12/202314:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
15/12/202314:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
05/12/202315:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
30/11/202313:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
28/11/202314:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
27/11/202312:48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:HUGEFSD Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:HUGE

Your Recent History

LSE
GDR
Genedrive
LSE
VAST
Vast Resources
LSE
BIRD
Blackbird
LSE
LLOY
Lloyds Banking
LSE
GKP
Gulf Keystone Petroleum
LSE
JWNG
Jaywing
LSE
BARC
Barclays
LSE
SRT
Srt Marine Systems
LSE
TAVI
Tavistock Investments
LSE
SRSP
Sirius Petroleum
LSE
PHE
Powerhouse Energy
LSE
SHED
Urban Logistics Reit
LSE
AGL
Angle
LSE
HMI
Harvest Minerals
LSE
ITV
Itv
LSE
PANR
Pantheon Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved